Resources
Continuous glucose monitoring
Comprehensive e-learning resource, delivered in five CPD modules. Free to healthcare professionals.
(Source: Primary Care Diabetes & Obesity Society)
Type 2 diabetes and obesity education programme
Registration open to healthcare professionals for new, free programme.
(Source: EDEN)
Guidance
Overweight and obesity management
New guidance from NICE (NG246).
(Source: NICE)
ADA Standards of Care in Diabetes – 2025
Latest clinical practice recommendations of the American Diabetes Association, providing the components of diabetes care, general treatment goals and tools to evaluate quality of care. [Open access]
(Source: Diabetes Care)
Medicines and devices
NovoRapid® (insulin aspart) FlexTouch® 100 units/ml solution for injection 3 ml pre-filled pens
Updated communication on the discontinuation of this product.
(Source: DHSC)
Owen Mumford to discontinue Autopen insulin pens – here’s what you need to know
Details of affected devices and timescale for discontinuation.
(Source: Diabetes UK)
GLP-1 and dual GIP/GLP-1 RAs: potential risk of pulmonary aspiration during general anaesthesia or deep sedation
Advice for healthcare professionals.
(Source: MHRA)
Journals: Articles
Physical activity during pregnancy and preterm birth among women with gestational diabetes
Evidence for health benefits of moderate-to-vigorous intensity physical activity during pregnancy. [Open access]
(Source: JAMA Network Open)
Exploring the lived experience of women with gestational diabetes: A cross-sectional Irish national survey
The experiences and views of women in the Republic of Ireland. [Open access]
(Source: Diabetic Medicine)
The sugar-coated truth: The quality of diabetes health information on TikTok
Assessment of the type 1 diabetes health information found on this platform. [Open access]
(Source: Clinical Diabetes)
The real-life experiences of people living with overweight and obesity: A psychosocial perspective
The need for greater psychological support for people living with obesity. [Open access]
(Source: Diabetes, Obesity and Metabolism)
Health outcome priorities of people with multiple long-term conditions using the outcome prioritisation tool in the UK
Survey study assessing the feasibility and acceptability of the outcome prioritisation tool in a UK setting. [Open access]
Source: PLOS One)
A voice-based algorithm can predict type 2 diabetes status in USA adults: Findings from the Colive Voice study
Potential for an accessible, cost-effective and non-invasive screening tool. [Open access]
(Source: PLOS Digital Health)
Glycaemic control is still central in the hierarchy of priorities in type 2 diabetes management
A re-evaluation of the scientific evidence on optimising glycaemic control in diabetes care. [Open access]
(Source: Diabetologia)
Striving for early effective glycaemic and weight management in type 2 diabetes:
A narrative review
Emerging evidence for the importance of early optimisation of metabolic control in people with type 2 diabetes to improve long-term outcomes. [Open access]
(Source: Diabetes, Obesity and Metabolism)
Achievement of HbA1c and weight targets in adults with type 2 diabetes on once weekly injectable GLP-1 receptor agonist therapy in UK primary care
A retrospective, real-world study indicating unmet need for better clinical management of type 2 diabetes. [Open access]
(Source: Diabetes, Obesity and Metabolism)
Evidence on the effectiveness and equity of population-based policies to reduce the burden of type 2 diabetes
Review of the efficacy, cost effectiveness and equity of low-agency policies for the prevention of type 2 diabetes.
[Open access]
(Source: Diabetologia)
Trends in certifications of overall vision impairment and that due to diabetic retinopathy/maculopathy in England and Wales, 2009/2010 to 2019/2020
Data show a fall in certifiable eye disease, but situation regarding the burden of sight loss less clear.
(Source: BMJ Open)
Journals: Quick reads
Diabetes Distilled: Reframing the definition and diagnosis of clinical obesity
Consensus report advises definitions of clinical and pre-clinical obesity, according to the presence of obesity-related conditions and dysfunction. [Open access]
(Source: Diabetes & Primary Care)
Childhood type 2 risk and beta-cell therapy in type 1: Research highlights November 2024
A selection of recent exciting diabetes research developments, including study findings that suggest semaglutide is associated with reduced risk of Alzheimer’s disease diagnosis.
(Source: Diabetes UK)
Position statements
Glucagon-like peptide-1 agonists and oral contraception
Recommendations for women using GLP-1 RAs, including a patient information leaflet.
(Source: The Faculty of Sexual Health & Reproductive Healthcare)
The use of automated insulin delivery around physical activity and exercise in type 1 diabetes
From the EASD and ISPAD, including current evidence and practice points for managing physical activity.
(Source: Diabetologia)
Journal of
Diabetes Nursing
Issue:
Vol:29 | No:01
What’s hot in diabetes nursing? February 2025
Resources
Continuous glucose monitoring
Comprehensive e-learning resource, delivered in five CPD modules. Free to healthcare professionals.
(Source: Primary Care Diabetes & Obesity Society)
Type 2 diabetes and obesity education programme
Registration open to healthcare professionals for new, free programme.
(Source: EDEN)
Guidance
Overweight and obesity management
New guidance from NICE (NG246).
(Source: NICE)
ADA Standards of Care in Diabetes – 2025
Latest clinical practice recommendations of the American Diabetes Association, providing the components of diabetes care, general treatment goals and tools to evaluate quality of care. [Open access]
(Source: Diabetes Care)
Medicines and devices
NovoRapid® (insulin aspart) FlexTouch® 100 units/ml solution for injection 3 ml pre-filled pens
Updated communication on the discontinuation of this product.
(Source: DHSC)
Owen Mumford to discontinue Autopen insulin pens – here’s what you need to know
Details of affected devices and timescale for discontinuation.
(Source: Diabetes UK)
GLP-1 and dual GIP/GLP-1 RAs: potential risk of pulmonary aspiration during general anaesthesia or deep sedation
Advice for healthcare professionals.
(Source: MHRA)
Journals: Articles
Physical activity during pregnancy and preterm birth among women with gestational diabetes
Evidence for health benefits of moderate-to-vigorous intensity physical activity during pregnancy. [Open access]
(Source: JAMA Network Open)
Exploring the lived experience of women with gestational diabetes: A cross-sectional Irish national survey
The experiences and views of women in the Republic of Ireland. [Open access]
(Source: Diabetic Medicine)
The sugar-coated truth: The quality of diabetes health information on TikTok
Assessment of the type 1 diabetes health information found on this platform. [Open access]
(Source: Clinical Diabetes)
The real-life experiences of people living with overweight and obesity: A psychosocial perspective
The need for greater psychological support for people living with obesity. [Open access]
(Source: Diabetes, Obesity and Metabolism)
Health outcome priorities of people with multiple long-term conditions using the outcome prioritisation tool in the UK
Survey study assessing the feasibility and acceptability of the outcome prioritisation tool in a UK setting. [Open access]
Source: PLOS One)
A voice-based algorithm can predict type 2 diabetes status in USA adults: Findings from the Colive Voice study
Potential for an accessible, cost-effective and non-invasive screening tool. [Open access]
(Source: PLOS Digital Health)
Glycaemic control is still central in the hierarchy of priorities in type 2 diabetes management
A re-evaluation of the scientific evidence on optimising glycaemic control in diabetes care. [Open access]
(Source: Diabetologia)
Striving for early effective glycaemic and weight management in type 2 diabetes:
A narrative review
Emerging evidence for the importance of early optimisation of metabolic control in people with type 2 diabetes to improve long-term outcomes. [Open access]
(Source: Diabetes, Obesity and Metabolism)
Achievement of HbA1c and weight targets in adults with type 2 diabetes on once weekly injectable GLP-1 receptor agonist therapy in UK primary care
A retrospective, real-world study indicating unmet need for better clinical management of type 2 diabetes. [Open access]
(Source: Diabetes, Obesity and Metabolism)
Evidence on the effectiveness and equity of population-based policies to reduce the burden of type 2 diabetes
Review of the efficacy, cost effectiveness and equity of low-agency policies for the prevention of type 2 diabetes.
[Open access]
(Source: Diabetologia)
Trends in certifications of overall vision impairment and that due to diabetic retinopathy/maculopathy in England and Wales, 2009/2010 to 2019/2020
Data show a fall in certifiable eye disease, but situation regarding the burden of sight loss less clear.
(Source: BMJ Open)
Journals: Quick reads
Diabetes Distilled: Reframing the definition and diagnosis of clinical obesity
Consensus report advises definitions of clinical and pre-clinical obesity, according to the presence of obesity-related conditions and dysfunction. [Open access]
(Source: Diabetes & Primary Care)
Childhood type 2 risk and beta-cell therapy in type 1: Research highlights November 2024
A selection of recent exciting diabetes research developments, including study findings that suggest semaglutide is associated with reduced risk of Alzheimer’s disease diagnosis.
(Source: Diabetes UK)
Position statements
Glucagon-like peptide-1 agonists and oral contraception
Recommendations for women using GLP-1 RAs, including a patient information leaflet.
(Source: The Faculty of Sexual Health & Reproductive Healthcare)
The use of automated insulin delivery around physical activity and exercise in type 1 diabetes
From the EASD and ISPAD, including current evidence and practice points for managing physical activity.
(Source: Diabetologia)
Diabetic kidney disease: Part 1 – pathology, prevalence, risk factors, problems, screening and monitoring
Guidance on tirzepatide prescribing for obesity in England released
Why is the incidence of DKA at diagnosis of type 1 diabetes increasing in children and young people?
AI predicts risk of kidney disease from eye-screening images
Insulin management: Treatment choices and frailty
Latest news: GLP-1 agonists safety update, and National Diabetes Experience Survey results
Supporting people with diabetes through life’s journey
A review of the nature of DKD and its clinical consequences.
6 Apr 2025
NHS England to allow weight-loss injections for prioritised patient cohorts from late June.
5 Apr 2025
The risk factors and what might be done to address them.
24 Mar 2025
Analysis of retinal screening images detects future disease risk in asymptomatic individuals.
21 Mar 2025